정맥 채혈 시장 : 세계 예측(2026-2032년)

The Venous Blood Collection Market is projected to grow by USD 6.95 billion at a CAGR of 5.10% by 2032.

Venous Blood Collection Executive Summary

Venous blood collection is a foundational component of modern diagnostics, supporting clinical chemistry, hematology, coagulation testing, immunology, blood banking, infectious disease screening, therapeutic drug monitoring, and chronic disease management. As healthcare systems increase reliance on laboratory-confirmed decision-making, the quality of venipuncture, specimen handling, anticoagulant selection, tube labeling, transport, and pre-analytical control has become central to patient safety and diagnostic accuracy. Global clinical practice is shaped by established guidance from the World Health Organization and clinical laboratory standards bodies, which emphasize correct patient identification, infection prevention, appropriate order of draw, avoidance of hemolysis, and timely specimen processing.

The venous blood collection landscape is also being influenced by demographic and epidemiological changes. Aging populations, the rising burden of diabetes, cardiovascular disease, kidney disease, cancer, autoimmune disorders, and infectious disease surveillance programs continue to increase the importance of reliable phlebotomy and specimen collection workflows. At the same time, healthcare providers are prioritizing safer needle technologies, evacuated blood collection systems, pre-labeled and barcoded tubes, closed collection devices, and workflow integration with laboratory information systems. The executive priority is no longer limited to collection efficiency; it now includes specimen integrity, worker safety, patient experience, traceability, regulatory compliance, and operational resilience across hospitals, diagnostic laboratories, blood collection centers, and ambulatory care settings.

Transformative Shifts in the Venous Blood Collection Landscape

The venous blood collection sector is undergoing transformative shifts driven by the convergence of safety engineering, laboratory automation, decentralized care, and stricter quality governance. Needlestick injury prevention remains a major occupational health priority, encouraging the adoption of safety-engineered needles, blood collection sets, and needle shielding mechanisms aligned with workplace safety regulations and infection prevention standards. Simultaneously, laboratories are increasing focus on reducing pre-analytical errors, which are widely recognized in clinical laboratory literature as a leading source of diagnostic testing variability. This has elevated demand for standardized phlebotomy protocols, specimen tracking, digital identification, and staff competency programs.

Another major shift is the movement of blood collection beyond traditional hospital settings into outpatient laboratories, home healthcare programs, community clinics, and mobile collection models. This shift requires more robust logistics, temperature control, chain-of-custody documentation, and user-friendly collection products suitable for varied care environments. Sustainability is also influencing procurement decisions, with healthcare systems assessing packaging reduction, plastic use, waste segregation, and disposal requirements for sharps and biohazardous materials. In parallel, demand for specialized collection tubes and additives is increasing as molecular diagnostics, liquid biopsy, pharmacogenomics, and biomarker-based monitoring require improved specimen stabilization. These changes are reshaping procurement strategies from price-led purchasing toward total quality, compliance, and lifecycle performance.

Cumulative Impact of Artificial Intelligence on Venous Blood Collection

Artificial intelligence is beginning to influence venous blood collection through its cumulative impact on workflow optimization, error reduction, training, demand planning, and laboratory connectivity. AI-enabled scheduling and routing tools can help optimize phlebotomy rounds, reduce patient wait times, and improve staff allocation in hospitals and outpatient collection centers. In laboratory operations, machine learning models are increasingly applied to identify patterns associated with hemolyzed, clotted, mislabeled, underfilled, or delayed specimens, enabling quality teams to target interventions at high-risk collection points and improve pre-analytical performance.

AI also strengthens traceability when integrated with barcode systems, electronic health records, and laboratory information systems. Predictive analytics can support inventory planning for collection tubes, needles, safety devices, tourniquets, labels, and transport materials by using historical test volumes and seasonal care patterns. In training, simulation platforms and digital competency tools can provide standardized feedback on vein assessment, tube order, patient identification, and specimen handling. However, AI adoption in this field depends on validated datasets, cybersecurity controls, interoperability, workforce acceptance, and compliance with medical device, data protection, and clinical governance requirements. The strongest near-term value lies in decision support and quality monitoring rather than replacing skilled phlebotomy professionals.

Key Regional Insights Across Global Venous Blood Collection

Asia-Pacific is experiencing rising demand for standardized venous blood collection as healthcare infrastructure expands, public health screening programs grow, and chronic disease testing increases across large populations. Countries in this region are strengthening diagnostic capacity through hospital modernization, laboratory accreditation, and broader access to outpatient testing, while also managing diverse operating conditions across urban tertiary centers and rural care networks. North America is characterized by mature clinical laboratory systems, strong emphasis on occupational safety, electronic ordering, barcode-based specimen tracking, and compliance-driven phlebotomy practices. The region's high use of preventive screening, chronic disease monitoring, and specialized diagnostics supports continued attention to safety-engineered products and pre-analytical quality control.

Latin America is advancing through expanding private and public diagnostic networks, increasing adoption of evacuated tube systems, and improved laboratory quality programs, though access and standardization can vary between metropolitan and underserved areas. Europe is shaped by rigorous regulatory expectations, established healthcare quality systems, and strong attention to worker safety, environmental management, and laboratory accreditation. The Middle East is investing in hospital infrastructure, diagnostic modernization, and preventive healthcare initiatives, particularly in urban health systems, creating demand for reliable venous collection workflows, skilled phlebotomy services, and integrated laboratory operations. Africa presents a highly varied landscape in which venous blood collection is essential for infectious disease testing, maternal and child health programs, transfusion services, and chronic disease diagnosis; priorities include training, supply continuity, specimen transport, biosafety, and access to quality-assured laboratory services across decentralized care settings.

Key Group Insights for Venous Blood Collection Adoption

ASEAN healthcare systems are strengthening diagnostic access through public hospital networks, private laboratories, and regional health initiatives, making venous blood collection quality increasingly important for infectious disease surveillance, noncommunicable disease management, and maternal health testing. The GCC is distinguished by strong investment in hospital infrastructure, medical tourism ambitions, digital health adoption, and centralized laboratory networks, supporting demand for high-standard phlebotomy practices, safe collection devices, and traceable sample handling. The European Union operates within a highly regulated healthcare and medical device environment, where quality management, patient safety, data protection, and sustainability considerations influence procurement and laboratory workflow decisions across member states.

BRICS countries represent diverse but influential healthcare systems with large patient populations, expanding diagnostic capacity, and increasing focus on domestic healthcare manufacturing, public health screening, and laboratory modernization. G7 countries generally reflect advanced diagnostic ecosystems, broad insurance or public healthcare coverage models, high laboratory automation, and strong adoption of safety and quality standards, making them important reference markets for best practices in venous blood collection. NATO member countries span North America and Europe and include healthcare systems with robust emergency preparedness, military medical requirements, and public health readiness frameworks, where reliable blood collection, transfusion support, and specimen logistics are important for both routine and crisis-response healthcare operations.

Key Country Insights in Venous Blood Collection

The United States has a highly developed diagnostic testing environment supported by extensive hospital networks, outpatient laboratories, electronic ordering systems, and strong occupational safety requirements that drive adoption of safety-engineered venous blood collection products. Canada emphasizes publicly funded healthcare delivery, laboratory quality management, and access across geographically dispersed populations, making specimen transport and standardized phlebotomy protocols important. Mexico continues to expand diagnostic access through public institutions and private laboratories, with increasing relevance of chronic disease testing and urban outpatient collection services. Brazil's large healthcare system relies on venous blood collection for infectious disease testing, chronic disease monitoring, prenatal care, and hospital diagnostics, while logistics and regional access remain important considerations.

The United Kingdom is shaped by national healthcare pathways, primary care-linked diagnostics, and laboratory consolidation initiatives, supporting standardized specimen collection and digital traceability. Germany has a strong clinical laboratory infrastructure, strict quality expectations, and high diagnostic utilization across hospital and ambulatory care. France emphasizes regulated healthcare delivery, laboratory accreditation, and patient safety, while Italy and Spain continue to support hospital-based and outpatient diagnostic testing for aging populations and chronic disease needs. Russia has broad regional healthcare requirements, with venous blood collection supporting hospital care, public health testing, and diagnostic access across major cities and remote areas.

China is rapidly strengthening laboratory capacity through hospital expansion, diagnostic modernization, and public health initiatives, with venous blood collection central to routine testing, infectious disease control, and advanced diagnostics. India's high population base, growing diagnostic networks, and rising burden of diabetes, cardiovascular disease, and thyroid disorders make reliable blood collection and specimen quality critical across both urban and semi-urban settings. Japan's aging population and advanced healthcare system support high standards in phlebotomy, chronic disease monitoring, and laboratory automation. Australia's healthcare system places importance on quality-assured pathology services across large geographic distances, requiring robust collection and transport systems. South Korea combines advanced hospital infrastructure, high digital health adoption, and strong diagnostic capabilities, supporting efficient, traceable, and safety-focused venous blood collection workflows.

Actionable Recommendations for Venous Blood Collection Leaders

Industry leaders should prioritize end-to-end pre-analytical quality, from patient identification and tube selection to specimen transport and laboratory receipt. Investments in safety-engineered collection devices, standardized order-of-draw training, digital labeling, barcode verification, and competency-based phlebotomy education can reduce avoidable errors and strengthen patient safety. Procurement teams should evaluate products not only on unit cost but also on hemolysis risk, fill accuracy, additive performance, safety mechanisms, compatibility with automation, packaging efficiency, and regulatory documentation.

Healthcare providers and suppliers should also prepare for decentralized collection by designing workflows suitable for outpatient, mobile, home-based, and rural care settings. This includes temperature-controlled transport, chain-of-custody procedures, clear instructions for specimen stability, and integration with laboratory information systems. Leaders should use quality indicators such as hemolysis rates, recollection rates, specimen rejection reasons, needlestick incidents, labeling errors, and turnaround time disruptions to guide continuous improvement. In parallel, organizations should monitor evolving requirements related to medical device regulation, sharps disposal, sustainability, data protection, and AI-enabled workflow tools. Strategic differentiation will come from combining safety, usability, traceability, clinical reliability, and environmental responsibility.

Research Methodology for Venous Blood Collection Insights

This executive summary is developed using a structured secondary research approach focused on verified clinical, regulatory, and healthcare operations sources. The methodology considers guidance from recognized public health bodies, clinical laboratory standards organizations, medical device regulatory frameworks, occupational safety requirements, peer-reviewed literature on pre-analytical quality, and documented healthcare infrastructure trends. Regional and country-level insights are synthesized from publicly available health system information, diagnostic access patterns, laboratory accreditation practices, demographic shifts, and disease burden indicators reported by authoritative institutions.

The analysis avoids speculative sizing, share estimation, or forecasting and instead focuses on evidence-backed qualitative assessment of demand drivers, workflow priorities, safety considerations, technology adoption, and implementation challenges. The research process emphasizes triangulation across clinical guidelines, regulatory documentation, public health data, and laboratory best-practice literature to ensure reliability. Key themes were assessed for relevance to hospitals, diagnostic laboratories, blood collection centers, ambulatory facilities, home healthcare providers, procurement teams, and medical device stakeholders involved in venous blood collection.

Conclusion: Quality, Safety, and Traceability Define the Future

Venous blood collection remains indispensable to accurate diagnosis, disease monitoring, transfusion support, and preventive healthcare. The sector is evolving from a procedural service into a quality-critical, digitally connected, and safety-focused component of the diagnostic value chain. Healthcare systems are placing greater emphasis on reducing pre-analytical errors, protecting workers from sharps injuries, improving patient experience, and ensuring traceable specimen movement from collection to analysis.

Regional and country dynamics show that priorities differ by healthcare maturity, infrastructure, regulatory expectations, and access needs, but the common direction is clear: safer devices, standardized training, better data integration, and stronger specimen integrity. Artificial intelligence, laboratory connectivity, and decentralized care models will further elevate the importance of disciplined collection workflows. Organizations that invest in quality governance, resilient supply chains, workforce competency, and patient-centered collection practices will be best positioned to support reliable diagnostics in increasingly complex healthcare environments.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Venous Blood Collection Market, by Product Type

• 7.1. Introduction
• 7.2. Blood Bags
• 7.3. Blood Collection Tube
  • 7.3.1. EDTA Tube
  • 7.3.2. Heparin Tube
  • 7.3.3. Microcontainer Tubes
  • 7.3.4. Microhematocrit Tubes
  • 7.3.5. Plasma Separation Tube
  • 7.3.6. Serum Separating Tube
  • 7.3.7. Vacuum Blood Collection Tubes
• 7.4. Lancets
• 7.5. Microfluidic System
• 7.6. Needles & Syringes
• 7.7. Venous Cannula
• 7.8. Warming Devices

8. Venous Blood Collection Market, by Technology

• 8.1. Introduction
• 8.2. Automated Collection Systems
• 8.3. Vacuum Collection Technology

9. Venous Blood Collection Market, by Material Type

• 9.1. Introduction
• 9.2. Ceramic
• 9.3. Glass
• 9.4. Plastic
  • 9.4.1. Polyethylene Terephthalate
  • 9.4.2. Polypropylene
• 9.5. Stainless Steel

10. Venous Blood Collection Market, by Application

• 10.1. Introduction
• 10.2. Intraoperative Blood Salvage
• 10.3. Vein Blood Gas Sampling
• 10.4. Venipuncture

11. Venous Blood Collection Market, by End User

• 11.1. Introduction
• 11.2. Blood Donation Centers
• 11.3. Diagnostic Centers
• 11.4. Hospitals & Clinics

12. Venous Blood Collection Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Venous Blood Collection Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Venous Blood Collection Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. FPNV Positioning Matrix, 2025
• 15.3. Market Concentration Analysis, 2025
  • 15.3.1. Concentration Ratio (CR)
  • 15.3.2. Herfindahl Hirschman Index (HHI)
• 15.4. Recent Developments & Impact Analysis, 2025
• 15.5. Product Portfolio Analysis, 2025
• 15.6. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Abbott Laboratories
• 16.2. AdvaCare International
• 16.3. Baxter International Inc.
• 16.4. Becton Dickinson and Company
• 16.5. Bio-Rad Laboratories, Inc.
• 16.6. Biosigma S.p.A.
• 16.7. Cardinal Health, Inc.
• 16.8. Demophorius Limited
• 16.9. ELITech Group by Bruker Corporation
• 16.10. FL MEDICAL s.r.l.
• 16.11. Fresenius Kabi AG
• 16.12. Greiner Bio-One International GmbH
• 16.13. Medtronic PLC
• 16.14. Narang Medical Ltd.
• 16.15. Nipro Europe Group Companies
• 16.16. Plymouth Tube Company LLC
• 16.17. Poly Medicure Limited
• 16.18. PTS Diagnostics by Sinocare
• 16.19. QIAGEN GmbH
• 16.20. SARSTEDT AG & Co. KG
• 16.21. Sekisui Medical Co., Ltd.
• 16.22. Terumo Corporation
• 16.23. Thermo Fisher Scientific Inc.
• 16.24. Zhejiang Gongdong Medical Technology Co., Ltd.